| Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
|---|
| 06/04/1997 | CN1150909A Carsickness plaster and carsickness drug |
| 06/04/1997 | CN1150908A Preparation of medicine for treating atrophic gastritis |
| 06/04/1997 | CN1150907A Traditional Chinese patent medicine for strengthening spleen and appetizing and its preparation method |
| 06/04/1997 | CN1150906A Umbellate pore fungus and poria cocos antidiarrhea oral liquid and its production technology |
| 06/04/1997 | CN1150905A 马海治瘫片 Mohair zhitan piece |
| 06/04/1997 | CN1150904A Kenading muscle and anti-paralysis tablet |
| 06/04/1997 | CN1150903A Digestant plaster formula and its production technology |
| 06/04/1997 | CN1150902A Medical discutient and analgesic plaster |
| 06/04/1997 | CN1150901A Concentrated aqueous solution of rotatory enzyme inhibitor |
| 06/04/1997 | CN1150900A Production technology of traditional Chinese medicine solid decoction |
| 06/04/1997 | CN1035039C Preparation method for dimethylamine tetracycline drug transmission system |
| 06/04/1997 | CN1035038C Preparation of pharmaceutical composition for preventing venereal disease |
| 06/03/1997 | US5635613 Process for preparing crystal forms and solvates of dirithromycin |
| 06/03/1997 | US5635609 Having stable membrane encapsulating particle core; cosmetics, drugs, reagents |
| 06/03/1997 | US5635540 Stabilized topical pharmaceutical preparations |
| 06/03/1997 | US5635539 Containing an oil that is not surface active or water soluble, a surfactant and water; oxygen transport agents, artificial blood, contrast agents for biological imaging |
| 06/03/1997 | US5635538 Fluorocarbon emulsions with reduced pulmonary gas-trapping properties |
| 06/03/1997 | US5635536 Emulsion suitable for administering a sphingolipid |
| 06/03/1997 | US5635520 Anti-ulcer compositions suitable for rectal administration |
| 06/03/1997 | US5635499 Medicinal products and pure preparations of melarsomine dihydrochloride, process for obtaining them and intermediate products obtained |
| 06/03/1997 | US5635497 Topical application compositions |
| 06/03/1997 | US5635493 Methods and compositions for poly-β-1-4-N-acetylglucosamine chemotherapeutics |
| 06/03/1997 | US5635492 Aqueous mixture of microbiocide and rhamsan gum which has high retention efficiency |
| 06/03/1997 | US5635491 Incorporation of maltose controls particle size |
| 06/03/1997 | US5635487 Drug delivery |
| 06/03/1997 | US5635380 Enhancement of nucleic acid transfer by coupling virus to nucleic acid via lipids |
| 06/03/1997 | US5635373 Bone morphogenic protein-5(BMP-5) and DNA encoding same |
| 06/03/1997 | US5635357 Stabilized microspheres and methods of preparation |
| 06/03/1997 | US5635238 Provides fast release of active material when wetted, typically by bodily fluids as in cosmetic use |
| 06/03/1997 | US5635216 Stable biocompatible, biodegradable polyester matrices containing dispersion of water soluble polypeptide hormones |
| 06/03/1997 | US5635215 Hydrophilic acrylic copolymer coated with cell adhesion promoter |
| 06/03/1997 | US5635214 Sorbent precipitated silica particulates |
| 06/03/1997 | US5635213 Pharmaceutical formulation |
| 06/03/1997 | US5635210 Forming a porous particulate support matrix; dispersing a drug; adding adjuvants, e.g., flavors, binders, effervescent agents; forming a tablet, applying a coating; easily swallowed |
| 06/03/1997 | US5635209 Mixing with a potassium iodide stabilizer, a disintegrant a lubricant and a carrier; photostability; heat resistance; humidity; shelf life |
| 06/03/1997 | US5635208 Mixing binder-wetted acetaminophen-filler-disintegrant granulation while spraying with diphenhydramine hydrochloride solution, spraying binder, drying |
| 06/03/1997 | US5635207 Subjecting aqueous medium containing oxygen binding protein to high intensity ultrasound conditions to promote crosslinking and form polymeric shell of specified size |
| 06/03/1997 | US5635206 Process for liposomes or proliposomes |
| 06/03/1997 | US5635205 Carrier system including local anesthetic, amphipathic polar lipid, nonpolar lipid comprising mixture of glycerol monocaprylate and glycerol monocaprate, wherein discrete lipid particles form in aqueous medium |
| 06/03/1997 | US5635204 Method for transdermal induction of anesthesia, analgesia or sedation |
| 06/03/1997 | US5635203 Contact adhesive layer having reservoirs containing mixtures of drugs and skin permeation enhancing nonionic surfactant, also with porous tie layer on reservoir surface close to skin |
| 06/03/1997 | US5635202 Micro-encapsulated lactobacilli for medical applications |
| 06/03/1997 | US5635200 Having polymeric or cellulosic binder and lipid coating |
| 06/03/1997 | US5635176 Pharmaceutical compositions containing IL-6 |
| 06/03/1997 | US5635172 Comprising a drug for controlling and treating ocular hypertension, an anionic mucomimetic polymer having carboxyl groups and a cation exchane resin |
| 06/03/1997 | US5635162 Hemostatic composition for treating gingival area |
| 06/03/1997 | US5635161 Pulmonary delivery |
| 06/03/1997 | US5635160 Dinucleotides useful for the treatment of cystic fibrosis and for hydrating mucus secretions |
| 06/03/1997 | US5635159 Aerosol drug formulations containing polyglycolyzed glycerides |
| 05/29/1997 | WO1997019354A1 Storage-stable particle, in particular carrier for carrier-bound reactions, and methods of producing said particle |
| 05/29/1997 | WO1997019184A1 Liposomal transfection method |
| 05/29/1997 | WO1997019108A1 Pulmonary surfactant peptide solubilization process |
| 05/29/1997 | WO1997018840A2 Therapeutic delivery using compounds self-assembled into high axial ratio microstructures |
| 05/29/1997 | WO1997018839A1 Solid mixtures of cyclodextrins prepared via melt-extrusion |
| 05/29/1997 | WO1997018835A1 Enzymatic method and compositions for treating intravitreal hemorrhagic blood |
| 05/29/1997 | WO1997018820A1 External preparation for curing lesioned tissues |
| 05/29/1997 | WO1997018814A1 Pharmaceutical formulations |
| 05/29/1997 | WO1997018802A1 Pharmaceutical compositions comprising flurbiprofen |
| 05/29/1997 | WO1997018799A1 Use of a tnf alpha antagonist for treating neurogenic skin redness |
| 05/29/1997 | WO1997018798A1 Prompt-release pharmaceutical compositions |
| 05/29/1997 | WO1997018797A1 Electrostatically charged nasal application device and process |
| 05/29/1997 | WO1997018796A1 Fast-melt solid dosage form and method of making same |
| 05/29/1997 | WO1997018782A1 Treatment with calcium channel blockers for drug-induced hypersensitivity |
| 05/29/1997 | WO1997015288A3 Method and preparations for stabilizing biological materials by drying methods without freezing |
| 05/29/1997 | WO1997013500A3 LIPOSOME FORMULATIONS OF 5β STEROIDS |
| 05/29/1997 | WO1997004748A3 Enhanced artificial viral envelopes for cellular delivery of therapeutic substances |
| 05/29/1997 | CA2238344A1 Fast-melt solid dosage form and method of making same |
| 05/29/1997 | CA2236864A1 Electrostatically charged nasal application device and process |
| 05/29/1997 | CA2232715A1 Pharmaceutical formulations |
| 05/28/1997 | EP0775494A1 Peroral immunogen composition and process for producing the same |
| 05/28/1997 | EP0775492A1 Use of salts of lanthanide, tin, zinc, manganese, yttrium, cobalt, strontium in skin composition |
| 05/28/1997 | EP0775488A1 Stable pharmaceutical composition on the basis of acetylsalicyclic acid and tocopherol |
| 05/28/1997 | EP0775485A1 New dosage form of hydroxocobalamin and its use in cyanide poisoning |
| 05/28/1997 | EP0775484A1 Surfactant free aerosol formulations containing bezlomethsone dipropionate |
| 05/28/1997 | EP0775483A1 Composition containing a polymer system and its use |
| 05/28/1997 | EP0775339A1 Current-to-pressure transducer with selectable, adjustable input filter |
| 05/28/1997 | EP0775213A1 Adenovirus comprising a gene coding for glutathion peroxidase |
| 05/28/1997 | EP0775203A1 Method of gene therapy using dna vectors without selection marker gene |
| 05/28/1997 | EP0775111A1 Stable vitamin a |
| 05/28/1997 | EP0774975A1 Use of starch for transdermal applications |
| 05/28/1997 | EP0774964A1 Controlled local delivery of chemotherapeutic agents for treating solid tumors |
| 05/28/1997 | EP0774963A1 Pharmaceutically stable oxaliplatinum preparation |
| 05/28/1997 | EP0774960A1 Composition for the selective release of an active ingredient |
| 05/28/1997 | EP0774959A1 A liposomal delivery system for biologically active agents |
| 05/28/1997 | EP0774958A1 Vesicle formulation |
| 05/28/1997 | EP0774957A1 Aqueous foamable composition |
| 05/28/1997 | EP0774956A1 PROCESS FOR PREPARING BECLOMETHASONE DIPROPIONATE FREON$m(3) CLATHRATE |
| 05/28/1997 | EP0774955A1 Improved bioadhesive pharmaceutical delivery system |
| 05/28/1997 | EP0774954A2 Hydrogel for the application of therapeutic and/or cosmetic active substances to the skin |
| 05/28/1997 | EP0774896A1 Gel formulation |
| 05/28/1997 | EP0690747B1 Extrusion and freeze-drying method for preparing particles containing an active ingredient |
| 05/28/1997 | EP0594707B1 Preparations comprising a fluorocarbon and a lipophilic/fluorophilic organic compound, and their uses |
| 05/28/1997 | EP0526511B1 Method and composition for treatment of central nervous systems disease states associated with abnormal amyloid beta protein |
| 05/28/1997 | CN1150764A Polymeric microbeads and method of preparation |
| 05/28/1997 | CN1150757A Process for producing active material composition and active material composition |
| 05/28/1997 | CN1150756A Stable protein: phospholipid composition and method |
| 05/28/1997 | CN1150588A Method for preparing N-(4-phenelyl)-2-hydroxybenzamide drug composition and its use |
| 05/28/1997 | CN1150548A Drug for curing leukopenia and radiation damage |
| 05/28/1997 | CN1150547A External use emulsion for curing burn |
| 05/28/1997 | CN1150546A Hair regrowth liquid medicine |